We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.6B
AUM Growth
+$4.82B
Cap. Flow
+$3.68B
Cap. Flow %
8.65%
Top 10 Hldgs %
12.95%
Holding
2,932
New
107
Increased
1,463
Reduced
1,212
Closed
134

Sector Composition

Rank Sector Weight
1 Technology 12.83%
2 Financials 12.17%
3 Healthcare 10.88%
4 Industrials 10.2%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSFS icon
2451
WSFS Financial
WSFS
$4.19B
$419K ﹤0.01%
8,584
-14
-0.2% -$632
NYRT
2452
DELISTED
New York REIT, Inc.
NYRT
$418K ﹤0.01%
5,322
-2,015
-27% -$167K
PR
2453
Permian Resources
PR
$17.5B
$417K ﹤0.01%
23,248
+5,848
+34% +$97.9K
TOUR
2454
Tuniu
TOUR
$53.8M
$416K ﹤0.01%
5,321
+561
+12% +$43.5K
RAMP icon
2455
LiveRamp
RAMP
$2.3B
$413K ﹤0.01%
16,790
+2,290
+16% +$56.2K
MIK
2456
DELISTED
Michaels Stores, Inc
MIK
$413K ﹤0.01%
19,213
-15,599
-45% -$318K
NEWR
2457
DELISTED
New Relic, Inc.
NEWR
$412K ﹤0.01%
8,271
+2,124
+35% +$100K
CHS
2458
DELISTED
Chicos FAS, Inc.
CHS
$411K ﹤0.01%
45,669
-16,541
-27% -$141K
PAYC icon
2459
Paycom
PAYC
$7.86B
$410K ﹤0.01%
5,468
-245
-4% -$17.5K
DGI
2460
DELISTED
DigitalGlobe Inc.
DGI
$409K ﹤0.01%
11,601
-40,994
-78% -$1.4M
LIVN icon
2461
LivaNova
LIVN
$4.53B
$405K ﹤0.01%
5,795
-1,074
-16% -$68.1K
PFS icon
2462
Provident Financial Services
PFS
$3.28B
$404K ﹤0.01%
15,126
-322
-2% -$8.16K
TXMD icon
2463
TherapeuticsMD
TXMD
$23.6M
$404K ﹤0.01%
1,527
-125
-8% -$36.1K
ACIW icon
2464
ACI Worldwide
ACIW
$5.83B
$401K ﹤0.01%
17,600
-20
-0.1% -$453
CPL
2465
DELISTED
CPFL Energia S.A.
CPL
$400K ﹤0.01%
23,319
-21,713
-48% -$370K
VSA
2466
VisionSys AI
VSA
$8.41M
$398K ﹤0.01%
11
+2
+22% +$84.1K
INWK
2467
DELISTED
InnerWorkings, Inc.
INWK
$398K ﹤0.01%
35,416
-32
-0.1% -$354
PHG icon
2468
Philips
PHG
$25.6B
$396K ﹤0.01%
12,664
-1,619
-11% -$47.1K
LOXO
2469
DELISTED
Loxo Oncology, Inc
LOXO
$394K ﹤0.01%
+4,278
New +$332K
BDN
2470
Brandywine Realty Trust
BDN
$541M
$393K ﹤0.01%
22,444
-17,600
-44% -$299K
VWR
2471
DELISTED
VWR Corporation
VWR
$393K ﹤0.01%
11,864
-28,773
-71% -$951K
CBD
2472
DELISTED
Companhia Brasileira de Distribuicao
CBD
$392K ﹤0.01%
16,573
-6,469
-28% -$148K
SBH icon
2473
Sally Beauty Holdings
SBH
$1.54B
$389K ﹤0.01%
19,904
-2,807
-12% -$55.2K
DKL icon
2474
Delek Logistics
DKL
$3.09B
$388K ﹤0.01%
+12,407
New +$390K
PAK
2475
DELISTED
Global X MSCI Pakistan ETF
PAK
$387K ﹤0.01%
6,655
-2,145
-24% -$131K

Similar funds

Guggenheim Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Guggenheim Capital held 2,932 positions worth $42.6B, up 13% from $37.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital deployed $3.68B of net new capital in Q3 2017, opening 107 new positions and adding to 1,463 existing holdings. Its largest new stake was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $46.6M trimmed.

  • Guggenheim Capital's largest Q3 2017 buy was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.
  • Guggenheim Capital added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2017, an estimated $209M increase.
  • Guggenheim Capital's biggest Q3 2017 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $46.6M.
  • Guggenheim Capital fully exited Reynolds American Inc in Q3 2017, selling an estimated $68.3M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $42.6B portfolio in Q3 2017.
  • Guggenheim Capital opened 107 new positions and closed 134 in Q3 2017.
  • Guggenheim Capital's portfolio value rose 13% quarter-over-quarter to $42.6B.

Based on Guggenheim Capital's 13F filing for Q3 2017, filed 14 Nov 2017.